Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

The Lancet Oncology - Tập 11 Số 11 - Trang 1048-1056 - 2010
Silvia de Sanjosé1,2, Wim Quint3, Laia Alemany1,2, D.T. Geraets3, Jo Ellen Klaustermeier1,2, Belén Lloveras4,2, Sara Tous2, Ana Félix5, Luis Eduardo Bravo6, Hai-Rim Shin7, Carlos Vallejos8, Patricia Alonso de Ruı́z9, Marcus Aurelho de Lima10, Núria Guimerà2, Omar Clavero2, María Alejo11,2, Antonio Llombart‐Bosch12, Chou Cheng-Yang13, Sílvio Tatti14, Elena Kasamatsu15, Ermina Iljazović16, Michael Odida17, Rodrigo Prado18, Muhieddine Seoud19, Magdalena Grce20, Alp Usubütün21, Asha Jain22, Gustavo Adolfo Hernandez Suarez23, Luis Estuardo Lombardi24, Aekunbiola Banjo25, Clara Menéndez26, Efren J. Domingo27, Julio Velasco28, Ashrafun Nessa29, Saibua C Bunnag Chichareon30, You‐Lin Qiao31, Enrique Lerma32, Suzanne M. Garland33, Toshiyuki Sasagawa34, Annabelle Ferrera35, Doudja Hammouda36, Luciano Mariani37, Adela Pelayo38, I Steiner39, Esther Oliva40, Chris J.L.M. Meijer41, Waleed Al-Jassar42, Eugénia Cruz43, Thomas C. Wright44, A Puras45, Cecilia Llave46, Maria Tzardi47, Θεόδωρος Αγοραστός48, Victoria García-Barriola49, Christine Clavel50, Jaume Ordï51, Miguel Andújar52, Xavier Castellsagué1,2, Gloria Inés Sánchez53, Andrzej Nowakowski54, Jacob Bornstein55, Nubia Muñóz2, F. Xavier Bosch2
1CIBER en Epidemiología y Salud Pública, Barcelona, Spain
2IDIBELL, Institut Català d'Oncologia-Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain
3DDL Diagnostic Laboratory, Voorburg, Netherlands
4Hospital del Mar, Barcelona, Spain
5Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
6Hospital Universitario del Valle, Cali, Colombia
7National Cancer Centre, Seoul, South Korea
8Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
9Hospital General de México, Facultad de Medicina, Universidad Nacional Autónoma de México, México, México
10Laboratório de Anatomia Patológica e citologia, Associação de Combate ao Câncer do Brasil Central, Hospital Dr Hélio Angotti, PATMED, Uberada, Brazil
11Hospital General de l’Hospitalet, L’Hospitalet de Llobregat, Barcelona, Spain
12Facultad de Medicina, Universidad de Valencia, Valencia, Spain
13National Cheng Kung University Medical College, Taiwan Association of Gynecologic Oncologists, Tainan, Taiwan
14Hospital de Clínicas “José de San Martín” Universidad de Buenos Aires, Buenos Aires, Argentina
15Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay
16Polyclinic for Laboratory Diagnostic, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina
17Uganda Makerere University, Kampala, Uganda
18Centro de Oncología Preventiva, Facultad de Medicina, Universidad de Chile, Santiago, Chile
19American University of Beirut Medical Centre, Beirut, Lebanon
20Rudjer Boskovic Institute, Division of Molecular Medicine, Zagreb, Croatia
21Medical School, Department of Pathology, Hacettepe University, Ankara, Turkey
22Cancer Prevention and Relief Society, Raipur, India
23Instituto Nacional de Cancerología, Bogotá, Colombia
24Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva, Hospital General San Juan de Dios, Guatemala, Guatemala
25Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
26Barcelona Centre for International Health Research, Hospital Clinic and Universitat de Barcelona, and Manhiça Health Research Centre, Barcelona, Spain
27University of the Philippines College of Medicine‐Philippine General Hospital, Manila, Philippines;
28Hospital San Agustín, Avilés, Spain
29Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
30Faculty of Medicine, Prince of Songkla University, Hat-Yai, Songkhla, Thailand
31Cancer Institute, Chinese Academy of Medical Sciences and Peking, Union Medical College, Beijing, China
32Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
33Royal Women's Hospital, University of Melbourne, Melbourne, VIC, Australia
34Kanazawa University Hospital, Kanazawa, Japan
35Escuela de Microbiología, Universidad Autónoma de Honduras, Tegucigalpa, Honduras
36Registre des Tumeurs d'Alger, National Institute of Health, Algiers, Algeria
37Regina Elena Cancer Institute, Rome, Italy
38Clínica San Carlos, Madrid, Spain
39Fingerland Department of Pathology, Charles University Faculty of Medicine and Faculty Hospital, Hradec Králové, Czech Republic
40Massachusetts General Hospital, Boston, MA, USA
41Vrije Universiteit Medical Centre, Amsterdam, Netherlands
42Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
43Centro Regional de Oncologia Coimbra, Instituto Português de Oncologia, Coimbra, Portugal
44New York Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA
45Hospital Virgen del Camino, Pamplona, Spain
46Cervical Cancer Prevention Centre, Cancer Institute (University of the Philippines, College of Medicine, Philippine General Hospital), Manila, Philippines
47Medical School of University of Crete, Crete, Greece
48Aristotle University of Thessaloniki, Thessaloniki, Greece
49Universidad Central de Venezuela, Caracas, Venezuela
50Centre Hospitaliere Universitaire Reims, Laboratoire Pol Bouin, Hôpital Maison Blanche, Reims, France
51CRESIB-Hospital Clínic, Barcelona, Spain
52Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain
53Universidad de Antioquía, Medellín, Colombia
54Medical University of Lublin, Lublin, Poland
55Western Galilee Hospital, Nahariya, Israel

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ferlay, 2010

Castellsague, 2007, HPV and cervical cancer in the world. 2007 Report. WHO/ICO Information Centre on HPV and cervical cancer (HPV Information Centre), Vaccine, 25, C1

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641

de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033

Bouvard, 2009, A review of human carcinogens—part B: biological agents, Lancet Oncol, 10, 321, 10.1016/S1470-2045(09)70096-8

Bosch, 1995, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group, J Natl Cancer Inst, 87, 796, 10.1093/jnci/87.11.796

Munoz, 2004, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, 111, 278, 10.1002/ijc.20244

Smith, 2007, Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, Int J Cancer, 121, 621, 10.1002/ijc.22527

Wheeler, 2009, Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States, J Natl Cancer Inst, 101, 475, 10.1093/jnci/djn510

Clifford, 2008, Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix, Int J Cancer, 122, 1684, 10.1002/ijc.23282

Schiffman, 2009, Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline, Infect Agent Cancer, 4, 8, 10.1186/1750-9378-4-8

Kleter, 1999, Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus, J Clin Microbiol, 37, 2508, 10.1128/JCM.37.8.2508-2517.1999

Insinga, 2008, A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States, Cancer Epidemiol Biomarkers Prev, 17, 1611, 10.1158/1055-9965.EPI-07-2922

Wentzensen, 2009, Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants, Int J Cancer, 125, 2151, 10.1002/ijc.24528

Tsuda, 2003, Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm, Gynecol Oncol, 91, 476, 10.1016/j.ygyno.2003.08.019

Vinokurova, 2008, Type-dependent integration frequency of human papillomavirus genomes in cervical lesions, Cancer Res, 68, 307, 10.1158/0008-5472.CAN-07-2754

de Cremoux, 2009, Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype, Int J Cancer, 124, 778, 10.1002/ijc.24075

Khan, 2005, The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice, J Natl Cancer Inst, 97, 1072, 10.1093/jnci/dji187

Kjaer, 2006, The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period, Cancer Res, 66, 10630, 10.1158/0008-5472.CAN-06-1057

Bulk, 2007, Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months, Int J Cancer, 121, 361, 10.1002/ijc.22677

Franceschi, 2005, A study of the impact of adding HPV types to cervical cancer screening and triage tests, J Natl Cancer Inst, 97, 938, 10.1093/jnci/dji159

Munoz, 2009, Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women, Br J Cancer, 100, 1184, 10.1038/sj.bjc.6604972

Safaeian, 2009, Detection of precancerous cervical lesions is differential by human papillomavirus type, Cancer Res, 69, 3262, 10.1158/0008-5472.CAN-08-4192

Castle, 2004, Human papillomavirus in oral exfoliated cells and risk of head and neck cancer, J Natl Cancer Inst, 96, 1181, 10.1093/jnci/djh232

Thông tin
Thông tin xuất bản

The Lancet Oncology

Tập 11 Số 11

1048-1056

Thông tin tác giả